Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9)

Shuo Yu; Yang Li; Hui Ren; Hong Zhou; Qian Ning; Xue Chen; Tinghua Hu; Lan Yang

doi:10.1007/s00280-021-04275-5

Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9)

Shuo Yu
, Yang Li
, Hui Ren
, Hong Zhou
, Qian Ning
, Xue Chen
, Tinghua Hu
, Lan Yang

Research output: Contribution to journal › Comment/debate

Abstract

A correction to this paper has been published: https://doi.org/10.1007/s00280-021-04275-5.

Original language	English
Pages (from-to)	563
Number of pages	1
Journal	Cancer Chemotherapy and Pharmacology
Volume	88
Issue number	3
DOIs	https://doi.org/10.1007/s00280-021-04275-5
State	Published - Sep 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00280-021-04275-5

Fingerprint

Dive into the research topics of 'Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9)'. Together they form a unique fingerprint.

Cite this

Yu, S., Li, Y., Ren, H., Zhou, H., Ning, Q., Chen, X., Hu, T., & Yang, L. (2021). Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9). Cancer Chemotherapy and Pharmacology, 88(3), 563. https://doi.org/10.1007/s00280-021-04275-5

@article{cdff7223c97548279051f3ffdf3ea736,

title = "Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9)",

abstract = "A correction to this paper has been published: https://doi.org/10.1007/s00280-021-04275-5.",

author = "Shuo Yu and Yang Li and Hui Ren and Hong Zhou and Qian Ning and Xue Chen and Tinghua Hu and Lan Yang",

note = "Publisher Copyright: {\textcopyright} 2021, Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2021",

month = sep,

doi = "10.1007/s00280-021-04275-5",

language = "英语",

volume = "88",

pages = "563",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "3",

}

Yu, S, Li, Y, Ren, H, Zhou, H, Ning, Q, Chen, X, Hu, T & Yang, L 2021, 'Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9)', Cancer Chemotherapy and Pharmacology, vol. 88, no. 3, pp. 563. https://doi.org/10.1007/s00280-021-04275-5

Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9). / Yu, Shuo; Li, Yang; Ren, Hui et al.
In: Cancer Chemotherapy and Pharmacology, Vol. 88, No. 3, 09.2021, p. 563.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9)

AU - Yu, Shuo

AU - Li, Yang

AU - Ren, Hui

AU - Zhou, Hong

AU - Ning, Qian

AU - Chen, Xue

AU - Hu, Tinghua

AU - Yang, Lan

PY - 2021/9

Y1 - 2021/9

N2 - A correction to this paper has been published: https://doi.org/10.1007/s00280-021-04275-5.

AB - A correction to this paper has been published: https://doi.org/10.1007/s00280-021-04275-5.

UR - https://www.scopus.com/pages/publications/85104277406

U2 - 10.1007/s00280-021-04275-5

DO - 10.1007/s00280-021-04275-5

M3 - 评论/辩论

C2 - 33856532

AN - SCOPUS:85104277406

SN - 0344-5704

VL - 88

SP - 563

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

IS - 3

ER -

Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1 (Cancer Chemotherapy and Pharmacology, (2021), 87, 2, (207-215), 10.1007/s00280-020-04188-9)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this